Clinical Trial: Satralizumab in Aneurysmal Subarachnoid Hemorrhage
Study Status: NOT_YET_RECRUITING
Recruit Status: NOT_YET_RECRUITING
Condition: Aneurysmal Subarachnoid Hemorrhage
Study Type: INTERVENTIONAL
Official Title: A Phase 1 Clinical Trial of Satralizumab as a Treatment for Aneurysmal Subarachnoid Hemorrhage
Brief Summary:
In this study, satralizumab will be administered to see whether satralizumab is safe in patients with a burst brain aneurysm and if it may prevent strokes in patients with a burst brain aneurysm.
Read more